Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

NCT04886063 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
423
Enrollment
INDUSTRY
Sponsor class

Stopped ATH-1017-AD-0203 was terminated after the Ph2/3 parent trial (LIFT-AD; NCT04488419) did not meet its primary endpoint, the GST score.

Conditions

Interventions

Sponsor

LeonaBio